Thalidomide-O-C6-NH2 TFA

Thalidomide-O-C6-NH2 TFA Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:Thalidomide-O-C6-NH2 TFA
CAS:1957235-99-2
Purity:98.00% Package:100 mg;500 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: TargetMol Chemicals Inc.
Tel:
Email: support@targetmol.com
Products Intro: Product Name:Thalidomide-O-C6-NH2 TFA
CAS:1957235-99-2
Package:100mg
Company Name: Xian confluore Biological Technology Co., Ltd.
Tel: +86-15680926068 +86-15680926068
Email: 1924344760@confluore.cn
Products Intro: Product Name:Thalidomide-O-C6-NH2 TFA
CAS:1957235-99-2
Purity:>99.00% Package:100mg
Company Name: Sichuan Wei Keqi Biological Technology Co., Ltd.  
Tel: 028-81700200 18116577057
Email: 3003855609@qq.com
Products Intro: Product Name:Thalidomide-O-C6-NH2TFA
CAS:1957235-99-2
Purity:98% Package:5mg;10mg;20mg;50mg;100mg;200mg;500mg;1g
Company Name: Xi'an Confluore Biological Technology Co., Ltd.  
Tel: +86-156-80926068 +86-15680926068
Email: 1924344760@qq.com
Products Intro: Product Name:Thalidomide-O-C6-NH2 TFA
CAS:1957235-99-2
Purity:99% HPLC Package:10MG;25MG;50MG;100MG;1G;5G Remarks:For customers outside China,please use the website:www.confluore.com

Thalidomide-O-C6-NH2 TFA manufacturers

Thalidomide-O-C6-NH2 TFA Basic information
Product Name:Thalidomide-O-C6-NH2 TFA
Synonyms:Thalidomide-O-C6-NH2 TFA;Thalidomide-4-O-C6-NH2 (TFA)
CAS:1957235-99-2
MF:C21H24F3N3O7
MW:487.43
EINECS:
Product Categories:
Mol File:1957235-99-2.mol
Thalidomide-O-C6-NH2 TFA Structure
Thalidomide-O-C6-NH2 TFA Chemical Properties
form Solid
color Light green to green
Safety Information
MSDS Information
Thalidomide-O-C6-NH2 TFA Usage And Synthesis
Thalidomide-O-C6-NH2 TFA Preparation Products And Raw materials
Tag:Thalidomide-O-C6-NH2 TFA(1957235-99-2) Related Product Information
4-((8-Aminooctyl)oxy)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl Thalidomide-O-C5-NH2 Thalidomide-linker 9 Thalidomide-linker 6 Hexanoic acid, 6-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]- 4-((6-aminohexyl)oxy)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione hydrochloride Butanoic acid, 4-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]- Heptanoic acid, 7-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]- Pentanoic acid, 5-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]- 1H-Isoindole-1,3(2H)-dione, 4-[(10-aminodecyl)oxy]-2-(2,6-dioxo-3-piperidinyl)- Propanoic acid, 3-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]- 1H-Isoindole-1,3(2H)-dione, 4-[(7-aminoheptyl)oxy]-2-(2,6-dioxo-3-piperidinyl)- Thalidomide-O-C6-NH2 Thalidomide-O-amido-C4-NH2 hydrochloride Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride Thalidomide-O-amido-PEG4-C2-NH2 hydrochloride Thalidomide-O-amido-C3-NH2 (TFA)

This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept